advisorsecurities master

TRAWTraws Pharma, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
22705
Ticker
TRAW
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2013-07-25
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
TRAW

Detail

Enriched 2026-08-14 20:47

Market cap
$8,118,221.66
Shares outstanding (class)
15,228,328
Shares outstanding (weighted)
15,228,328
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
7
Location
NEWTOWN, PA
Description

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib. The company has four clinical programs: (i) tivoxavir marboxil, (ii) ratutrelvir, (iii) narazaciclib (ON 123300), and (iv) rigosertib. It is focused on the development of tivoxavir marboxil and ratutrelvir. The company derives revenue from its collaboration and licensing agreements.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data